InvestDashboard.com



Skystar Bio Pharmaceutical Company (SKBI)



$0.05
52 Week Low
$0.05
2017-04-28 08:03:12 MDT
$0.3
52 Week High

Basic Info

Healthcare
Sector
Drug Manufacturers - Major
Industry
Other OTC
Stock Exchange
China
Country

Market Cap: $478,330Micro Cap (Less than $200M)
Analyst Recommendation:5Analysts say: Strong Sell. (1=Strong Buy, 5=Strong Sell)
Beta: 3.66 Higher Volatility Stock (beta over 1). Stock will go up more when the market goes up, and go down more when the market goes down. Beta of 1 means stock would match the S&P 500 Index.

Fundamentals

ForwardPE: Unknown
5 Yr Est Growth: Unknown
Yield: 0.00%
PEG-Y Ratio: N/A
Unknown PEG-Y ratio

Technicals

% Above 50 DayMA: -16.67%
% Above 200 DayMA: -58.33%
SKBI Performance 52 Weeks: -72.73%
S&P 500 Performance 52 Weeks: 12.50%
Downtrend is still intact: SKBI is below both 50 and 200 day Moving Averages. Currently beyond technical death cross because 50 Day MA is below 200 Day MA. Stock is closer to 52 Week Low than 52 Week High.
SKBI underperforming S&P 500 by -85.23% the last 52 Weeks. SKBI is close to 52 week low.

Profile


More Valuation

Price To Book: N/A
Unknown Price to Book Ratio
EV to EBITDA: 0.35
Great Value! A low EV to EBITDA ratio is great. Ideally, under 10. Under 17 is okay.

More Info

Field Value Average Comments
% Held By Insiders36.42% 17.28%Held by greater than average Insiders. Insiders can sway stock price. Watch insider buying and selling.
% Held By Institutions6.10% 62.07%Institutional percentage lower than average. Institutions may not have conviction in stock. Or is this a chance for institutions to invest more and boost price?
Short % Of Float0.46% 07.02% Shorted percentage less than average percent. Is stock loved? Do traders and investors believe in the stock?
Debt to Equity0.16 1.08 More Conservative Financing. Each industry has different Debt/Equity standard. Higher than 1 means company is taking on more leverage.
Profit Margin %22.48%-00.18% Profit Margin is better than the average! Good job.
Operating Margin %25.68%-05.28% Operating Margin greater than average percent. Good.
Return on Equity %9.61%-08.79% Return on Equity greater than average percent. Good.
Return on Assets %5.11%-01.29% Return on Assets greater than average percent. Good.
Revenue Per Employee $154,245.28 $883,096.70 Less than average Revenue Per Employee. This stock (or industry) might not be as efficient as others? Each industry might have a different standard.
Price to Cash 0.03 5.52 Lower than average Price to Cash. Meaning that the company has a higher percentage of cash as a percent of price. Cash can be good to cushion company during hard times, and as a potential source for buyouts or investments. However, some activists want the cash to be used by a company to buy its own stock, or to increase their dividend, or to invest the money.
CPEGY Ratio N/A 2.26Unknown.

Quick Thoughts

PROS:
  1. Price to Cash Ratio (0.03) is less than average. Good. Company has more cash as percentage of price than other companies.

  2. Better than average EV/EBITDA: 0.35

  3. Shorted less than average: 0.46%

  4. Profit Margin is positively good: 22.48%

  5. Operating Margin is positively good: 25.68%

  6. Return on Equity is positive: 9.61%

  7. Return on Assets is positive: 5.11%

  8. Debt To Equity is lower than 1: 0.16

CONS:
  1. Analysts do not like this stock: 5 (1=Strong Buy, 5=Strong Sell)

  2. Stock is Below Short Term 50DMA: -16.67%

  3. Stock is Below Long Term 200DMA: -58.33%

  4. Stock is closer to 52 week low.
  5. Stock underperforming S&P 500 over last 52 weeks: -85.23%


Headlines


Stock Chart


InvestDashboard.com SKBI: Skystar Bio Pharmaceutical Company

This page updated Thu Feb 1 22:00:01 MST 2018.